Cargando…
Tamoxifen-induced acute pancreatitis – a case report
Tamoxifen is a selective estrogen receptor modulator used for the treatment of oestrogen/progesterone receptor positive breast cancer. It has antagonistic or agonistic activity depending on the tissue location. Generally it causes mild and reversible side effects, however more serious ones including...
Autores principales: | Czyżykowski, Rafał, Połowinczak-Przybyłek, Joanna, Janiak, Anna, Herman, Jerzy, Potemski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520340/ https://www.ncbi.nlm.nih.gov/pubmed/26327832 http://dx.doi.org/10.5114/pm.2014.41089 |
Ejemplares similares
-
A retrospective evaluation of associations between chronic obstructive pulmonary disease, smoking, and efficacy of chemotherapy and selected laboratory parameters in patients with advanced non-small cell lung cancer
por: Czyżykowski, Rafał, et al.
Publicado: (2016) -
Real-World Evidence of Patient Outcome Following Treatment of Advanced Gastrointestinal Stromal Tumor (GIST) with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in Poland
por: Brzozowska, Melania, et al.
Publicado: (2019) -
Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland – real-world data
por: Brzozowska, Melania, et al.
Publicado: (2019) -
Remission of Thymoma on Steroid Therapy in a Patient With Atypical Thymoma-Associated Multiorgan Autoimmunity: A Case Report and Literature Review
por: Wrona, Ewa, et al.
Publicado: (2021) -
Synchronous primary ovarian and endometrial cancers: a series of cases and a review of literature
por: Dębska-Szmich, Sylwia, et al.
Publicado: (2014)